Home › NDC Lookup › RxCUI directory › RxCUI 312552

Potassium phosphate 305 MG / sodium phosphate, monobasic 700 MG Oral Tablet — RxCUI 312552

RxNorm drug concept · Semantic clinical drug
RxCUI 312552 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI312552
Official namePotassium phosphate 305 MG / sodium phosphate, monobasic 700 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asK+ phosphate 305 MG / Sodium Phosphate, Monobasic 700 MG Oral Tablet; potassium phosphate 305 MG / sodium phosphate 700 MG Oral Tablet; Pot phosphate 305 MG / Sodium Phosphate, Monobasic 700 MG Oral Tablet
FDA products mapped1
Package NDCs mapped1
Reported Medicaid activity (SDUD)232 prescriptions · 4 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Potassium Phosphates: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Great question. This IV form is used when your phosphate levels are too low to safely wait for a pill to work, or when you're not able to eat or take anything by mouth right now. I...
  • Why am I getting this through an IV instead of just taking a phosphorus pill?
  • It depends on how serious your kidney issues are. If you have severe kidney disease or are on dialysis, this specific product cannot be used — your kidneys would struggle to clear...
  • Is it safe to get this if I have kidney problems?
📖 Read our full Potassium Phosphates guide →

🕸️ Concept Web — How Potassium phosphate 305 MG / sodium phosphate, m... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Potassium phosphate 305 MG / sodium phosphate, monobasic 700 MG Oral Tablet RxCUI 312552

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 3

    The active substance itself — no strength, form, or brand attached yet.

    • Potassium phosphate 34322
    • Sodium phosphate, monobasic 235496
    • Potassium phosphate / sodium phosphate, monobasic 1009113
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • K-Phos No 2 217853
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Potassium phosphate / sodium phosphate, monobasic Oral Tablet 632001
    • Potassium phosphate / sodium phosphate, monobasic Oral Product 1165722
    • Potassium phosphate / sodium phosphate, monobasic Pill 1165723
    • Potassium phosphate / sodium phosphate, monobasic Oral Tablet [K-Phos No 2] 632491
    • K-Phos No 2 Oral Product 1167920
    • K-Phos No 2 Pill 1168502
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 4

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 16 of 17 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Potassium phosphate 305 MG SCDC · 541954
  • Sodium phosphate, monobasic 700 MG SCDC · 350978
  • Potassium phosphate / sodium phosphate, monobasic Oral Tablet SCDF · 632001
  • Potassium phosphate / sodium phosphate, monobasic Oral Product SCDG · 1165722
  • Potassium phosphate / sodium phosphate, monobasic Pill SCDG · 1165723

Brand-Name Concepts

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 312552 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00486-1134-01 100 TABLET, COATED in 1 BOTTLE (0486-1134-01) K-Phos No. 2 Beach Products, Inc. 1978-05-09
Observed labelers: Beach Products, Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ea · median
$1.0635
Range $1.0635–$1.0635 · middle 50% $1.0635–$1.0635 · 1 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.